West Pharmaceutical Services Inc (WST) — Capital Reinvestment Ratio

Latest as of March 2026: 0.47x

West Pharmaceutical Services Inc (WST) has a Capital Reinvestment Ratio of 0.47x as of March 2026, meaning it reinvests 0% of its operating cash flow ($89.90 Million) in capital expenditures ($42.70 Million). Check WST intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.47x
Capex / Operating Cash Flow

Operating Cash Flow

$89.90 Million
USD

Capital Expenditures

$42.70 Million
USD

Data as of

Mar 2026
Most recent filing

West Pharmaceutical Services Inc Capital Reinvestment Ratio (1989–2025)

This chart tracks West Pharmaceutical Services Inc's Capital Reinvestment Ratio across 37 annual periods. For the full cash flow conversion analysis, see West Pharmaceutical Services Inc cash conversion from operations.

Annual Capital Reinvestment Ratio for West Pharmaceutical Services Inc (1989–2025)

Year-by-year Capital Reinvestment Ratio for West Pharmaceutical Services Inc from 1989 to 2025. See West Pharmaceutical Services Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.38x $754.80 Million $285.90 Million ▼ -34.4%
2024 0.58x $653.40 Million $377.00 Million ▲ +23.8%
2023 0.47x $776.50 Million $362.00 Million ▲ +18.6%
2022 0.39x $724.00 Million $284.60 Million ▼ -9.4%
2021 0.43x $584.00 Million $253.40 Million ▲ +17.6%
2020 0.37x $472.50 Million $174.40 Million ▲ +7.2%
2019 0.34x $367.20 Million $126.40 Million ▼ -5.1%
2018 0.36x $288.60 Million $104.70 Million ▼ -27.0%
2017 0.50x $263.30 Million $130.80 Million ▼ -36.0%
2016 0.78x $219.40 Million $170.20 Million ▲ +25.2%
2015 0.62x $212.40 Million $131.60 Million ▲ +1.1%
2014 0.61x $182.90 Million $112.10 Million ▼ -13.3%
2013 0.71x $220.50 Million $155.80 Million ▲ +0.3%
2012 0.70x $187.40 Million $132.00 Million ▼ -4.9%
2011 0.74x $130.70 Million $96.80 Million ▲ +38.8%
2010 0.53x $138.30 Million $73.80 Million ▼ -31.8%
2009 0.78x $137.70 Million $107.80 Million ▼ -24.0%
2008 1.03x $135.00 Million $139.10 Million ▲ +2.9%
2007 1.00x $129.20 Million $129.40 Million ▲ +59.5%
2006 0.63x $143.80 Million $90.30 Million ▼ -0.6%
2005 0.63x $85.60 Million $54.10 Million ▼ -24.1%
2004 0.83x $68.90 Million $57.40 Million ▼ -5.2%
2003 0.88x $69.20 Million $60.80 Million ▲ +25.6%
2002 0.70x $53.90 Million $37.70 Million ▼ -48.1%
2001 1.35x $32.70 Million $44.10 Million ▲ +14.4%
2000 1.18x $48.60 Million $57.30 Million ▲ +29.1%
1999 0.91x $69.40 Million $63.40 Million ▼ -15.4%
1998 1.08x $71.00 Million $76.70 Million ▲ +112.6%
1997 0.51x $67.70 Million $34.40 Million ▲ +1.6%
1996 0.50x $63.40 Million $31.70 Million ▼ -26.4%
1995 0.68x $46.10 Million $31.30 Million ▲ +24.8%
1994 0.54x $49.80 Million $27.10 Million ▼ -37.5%
1993 0.87x $38.50 Million $33.50 Million ▲ +32.1%
1992 0.66x $34.00 Million $22.40 Million ▲ +14.7%
1991 0.57x $44.40 Million $25.50 Million ▼ -37.7%
1990 0.92x $36.00 Million $33.20 Million ▲ +15.3%
1989 0.80x $42.90 Million $34.30 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow